Chief Executive Officer
CurrentCurrent business priority is OTC sales of patented point-of-care diagnostic biomarker tests for detecting active and latent TB infections. Consumers and health care providers can get immediate access to life saving information. Worldwide TB is the second leading infectious killer after COVID-19. Approximately 1/4 of the worlds population is infected by.